Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-02-14

FDA Approved: ERLEADA — Original Application (Janssen Products, LP)

View source ↗

Summary

FDA approved ERLEADA (apalutamide) from Janssen Products, LP as the original NDA (NDA210951). It is approved for certain forms of prostate cancer, including non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERLEADA (apalutamide)

Snippet

ORIG AP for ERLEADA (APALUTAMIDE)